Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Cartelli, Daniele ^a   Goldwurm, Stefano ^b   Casagrande, Francesca ^a   Pezzoli, Gianni ^b   Cappelletti, Graziella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b PARKINSON INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; PARKIN; TUBULIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PACLITAXEL;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CYTOSKELETON; FEMALE; FIBROBLAST; GENE MUTATION; HEREDITY; HUMAN; IDIOPATHIC DISEASE; IN VIVO STUDY; MALE; MICROTUBULE; PARKINSON DISEASE; PATHOGENESIS; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION;

PARKINSONIA;

ADULT; AGED; FEMALE; FIBROBLASTS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MICROTUBULES; MIDDLE AGED; PACLITAXEL; PARKINSON DISEASE; PHENOTYPE; PHOSPHORYLATION;

EID: 84861306914     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037467     Document Type: Article

References (52)

1. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, et al. (2010) Missing pieces in the Parkinson's disease puzzle. Nat Med 16: 653-661.
2. Lesage S, Brice A, (2009) Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18: R48-59.
3. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, et al. (2000) Familial Parkinson's disease gene product parkin, is a ubiquitin-protein ligase. Nat Genet 2: 302-305.
4. MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, et al. (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52: 587-593.
5. Ren Y, Zhao J, Feng J, (2003) Parkin binds to α/β tubulin and increases their ubiquitination and degradation. J Neurosci 23: 3316-3324.
6. Gandhi PN, Wang X, Zhu X, Chen SG, et al. (2008) The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res 86: 1711-1720.
7. Mitchison T, Kirschener M, (1984) Dynamic instability of microtubule growth. Nature 312: 237-242.
8. Werstermann S, Weber K, (2003) Post-translational modifications regulate microtubule function. Nat Rev Mol Cell Biol 4: 938-947.
9. Yang F, Jiang Q, Zhao J, Ren Y, Sutton MD, et al. (2005) Parkin stabilizes microtubules through strong binding mediated by three independent domains. J Biol Chem 280: 17154-17162.
10. Gillardon F, (2009) Leucine-rich repeat kinase 2 phosphorylates brain tubulin-β isoform and modulates microtubule stability: a point of convergence in parkinsonian neurodegeneration? J Neurochem 110: 1514-1522.
11. Alim MA, Ma QL, Takeda K, Aizawa T, Matsubara M, et al. (2004) Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J Alzheimers Dis 6: 435-442.
12. Marshall LE, Himes RH, (1978) Rotenone inhibition of tubulin self-assembly. Biochim Biophys Acta 543: 590-594.
13. Cappelletti G, Surrey T, Maci R, (2005) The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as destabilising factor. FEBS Lett 579: 4781-4786.
14. Ren Y, Liu W, Jiang H, Jiang Q, Feng J, (2005) Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 280: 34105-34112.
15. Cartelli D, Ronchi C, Maggioni MG, Rodighiero S, Giavini E, et al. (2010) Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+-induced neurodegeneration. J Neurochem 115: 247-258.
16. Wu G, Wang X, Feng X, Zhang A, Li J, et al. (2011) Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease. Brain Res 1394: 105-111.
17. Rakovic A, Grünewald A, Seibler P, Ramirez A, Kock N, et al. (2010) Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients. Hum Mol Gen 19: 3124-3137.
18. Mortiboys H, Johansen KK, Aasly JO, Bandmann O, (2010) Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology 75: 2017-2020.
19. Grünewald A, Voges L, Rakovic A, Kasten M, Vandebona H, et al. (2010) Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts. PLoS ONE 5: e12962.
20. Auburger G, Klinkenberg M, Drost J, Marcus K, Morales-Gordo B, et al. (2012) Primary Skin Fibroblasts as a Model of Parkinson's Disease. Mol Neurobiol. [Epub ahead of print].
21. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ, (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42: 1142-6. Erratum in: Neurology 42: 1436.
22. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees A, (2001) What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992. Neurology 57: S34-38.
23. Goldwurm S, Zini M, Di Fonzo A, De Gaspari D, Siri C, et al. (2006) LRKK2 G2019S mutation and Parkinson's Disease: a clinical, neuropsychological and neuropsychiatric study in large Italian sample. Parkinsonism Relat Disord 12: 410-419.
24. Sironi F, Primignani P, Zini M, Tunesi S, Ruffmann C, et al. (2008) Parkin analysis in early Parkinson's disease. Parkinsonism Relat Disord 14: 326-333.
25. Kumar A, Greggio E, Beilina A, Kaganovich A, Chan D, et al. (2010) The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS ONE 5: e8730.
26. Cappelletti G, Maggioni MG, Tedeschi G, Maci R, (2003) Protein tyrosine nitration is triggered by nerve growth factor during neuronal differentiation of PC12 cells. Exp Cell Res 288: 9-20.
27. Ren Y, Jiang H, Yang F, Nakaso K, Feng J, (2009) Parkin Protects Dopaminergic Neurons against Microtubule-depolymerizing Toxins by Attenuating Microtubule-associated Protein Kinase Activation. J Biol Chem 284: 4009-4017.
28. Hur EM, Zhou FQ, (2010) GSK3 signalling in neural development. Nat. Rev. Neurosci. 11: 539-551.
29. Xiao D, Pinto JT, Soh JW, Deguchi A, Gundersen GG, et al. (2003) Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Res 63: 6825-6837.
30. Xie R, Nguyen S, McKeehan WL, Liu L, (2010) Acetylated microtubules are required for fusion of autophagosomes with lysosomes. BMC Cell Biol 11: 89.
31. Levy OA, Malagelada C, Greene LA, (2009) Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 14: 478-500.
32. Witt SN, (2010) Hsp70 molecular chaperones and Parkinson's disease. Biopolymers 93: 218-228.
33. Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, et al. (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8: 267-280.
34. Mitra G, Saha A, Gupta TD, Poddar A, Das KP, et al. (2007) Chaperone-mediated inhibition of tubulin self-assembly. Protein 67: 112-120.
35. Macejak DG, Luftig RB, (1991) Stabilization of actin filaments at early times after adenovirus infection and in heat-shocked cells. Virus Res 19: 31-45.
36. Mizushima N, Yoshimori T, Levine B, (2010) Methods in mammalian autophagy research. Cell 140: 313-326.
37. Tong Y, Yamaguchi H, Giaime E, Boyle S, Kopan R, et al. (2010) Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci USA 107: 9879-9884.
38. Rogowski K, van Dijk J, Magiera MM, Bosc C, Deloulme JC, et al. (2010) A Family of Protein-Deglutamylating Enzymes Associated with Neurodegeneration. Cell 143: 564-578.
39. Paturle-Lafanechere L, Manier M, Trigault N, Pirollet F, Mazarguil H, et al. (1994) Accumulation of delta 2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies. J Cell Sci 107: 1529-1543.
40. Janke C, Kneussel M, (2010) Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci 33: 362-372.
41. Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, et al. (2009) Axonal transport defects in neurodegenerative diseases. J Neurosci 29: 12776-12786.
42. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, et al. (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147: 893-906.
43. Piccoli G, Condliffe SB, Bauer M, Giesert F, Boldt K, et al. (2011) LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J Neurosci 31: 2225-2237.
44. Feinstein SC, Wilson L, (2005) Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death. Biochim Biophys Acta 1739: 268-279.
45. Kadir S, Astin JW, Tahatamouni L, Martin P, Nobes CD, (2011) Microtubule remodelling is required fro the front-rear polarity switch during contact inhibition of locomotion. J Cell Sci 124: 2642-2653.
46. Reed MJ, Ferara NS, Vernon RB, (2001) Impaired migration, integrin function, and actin cytoskeletal organization in dermal fibroblasts from a subset of aged human donors. Mech. Ageing Dev. 122: 1203-1220.
47. Schulze C, Wetzel F, Kueper T, Malsen A, Muhr G, et al. (2010) Stiffening of human skin fibroblasts with age. Biophys. J. 99: 2434-2442.
48. Liang Y, Li S, Wen C, Zhang Y, Guo Q, et al. (2008) Intrastriatal injection of colchicine induces striatonigral degeneration in mice. J. Neurochem. 106: 1815-1827.
49. Rostovtseva TK, Sheldon KL, Hassanzadeh E, Monge C, Saks V, et al. (2008) Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration. Proc Natl Acad Sci USA 105: 18746-18751.
50. Maldonado EN, Patnaik J, Mullins MR, Lemasters JJ, (2010) Free tubulin modulates mitochondrial membrane potential in cancer cells. Cancer Res 70: 10192-10201.
51. Choi WS, Palmiter RD, Xia Z, (2011) Loss of mitochondria complex I activity potentiates dopaminergic neuron death induced by microtubule dysfunction in a Parkinson's disease model. J Cell Biol 192: 873-882.
52. Caiazzo M, Dell'Anno MT, Dvoretskova E, Lazarevic D, Taverna S, et al. (2011) Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476: 224-227.